4//SEC Filing
Freddo James L 4
Accession 0001209191-10-060792
CIK 0001128495other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 7:40 PM ET
Size
6.0 KB
Accession
0001209191-10-060792
Insider Transaction Report
Form 4
Freddo James L
SVP, Drug Development and CMO
Transactions
- Award
Stock Option (Right to Buy)
2010-12-13+71,438→ 71,438 totalExercise: $1.02From: 2011-12-13Exp: 2020-12-12→ Common Stock (71,438 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable one year from the date of grant with the remaining shares subject to the option vesting in equal installments over the next three years such that all shares subject to the option will be fully vested and exercisable as of December 13, 2014.
Documents
Issuer
ANADYS PHARMACEUTICALS INC
CIK 0001128495
Entity typeother
Related Parties
1- filerCIK 0001368924
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 7:40 PM ET
- Size
- 6.0 KB